Candice Lue v. Teva Pharmaceuticals USA, Inc. et al.
Opinion
NOT FOR PUBLICATION
UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY
CHAMBERS OF MARTIN LUTHER KING COURTHOUSE SUSAN D. WIGENTON 50 WALNUT ST. UNITED STATES DISTRICT JUDGE NEW 97 A 3 R -6 K 45 , - N 5 J 9 0 0 3 7 101
September 2, 2026
Candice Lue P.O. Box 178 Great Meadows, NJ 07838 Pro se Plaintiff
Nina K. Markey Littler Mendelson, P.C. 1601 Cherry Street Suite 1400 Philadelphia, PA 19102 Counsel for Defendants Teva Pharmaceuticals, Shanna Clark, and Dor Hirschhorn
LETTER OPINION FILED WITH THE CLERK OF THE COURT
Re: Lue v. Teva Pharmaceuticals USA, Inc. et al., Civ. No. 25-1454 (SDW) (JBC)
Parties:
Before this Court is pro se Plaintiff Candice Lue’s (“Plaintiff”) Appeal of Magistrate Judge James B. Clark’s April 22, 2026 Order (the “Appeal” (D.E. 67)), in which Judge Clark denied Plaintiff’s motion requesting that her deposition be conducted remotely (D.E. 66). The Appeal is brought pursuant to Federal Rule of Civil Procedure (“Rule”) 72(a). Jurisdiction is proper pursuant to 28 U.S.C. § 1331. Venue is proper pursuant to 28 U.S.C. § 1392(b)(2). This Opinion is issued without oral argument pursuant to Rule 78. For the reasons set forth herein, Plaintiff’s Appeal is DENIED. I. FACTUAL AND PROCEDURAL BACKGROUND This Court will limit the factual and procedural background to those facts relevant to the pending appeal. Defendants Teva Pharmaceuticals, Shanna Clark, and Dor Hirschhorn (collectively, “Defendants”) have properly noticed Plaintiff’s deposition on multiple occasions, most recently for April 21, 2026. (D.E. 69 at 2.) The deposition was scheduled to occur at defense counsel’s offices in Newark, New Jersey. (Id.) Rather than comply with her discovery obligations, Plaintiff has requested that her deposition proceed remotely, asserting that she fears for her safety, that she does not trust Defendants, and that international human rights principles entitle her to a remote deposition. (D.E. 62, 67.) On April 22, 2026, Magistrate Judge Clark denied Plaintiff’s request for a remote deposition and ordered her to appear in-person. (D.E. 66.) On April 23, 2026, Plaintiff appealed Judge Clark’s Order, and timely briefing ensued. (D.E. 67, 69.) II. LEGAL STANDARD Rule 72(a) governs objections to a magistrate judge’s order on discovery disputes. Fed. R. Civ. P. 72(a). Under Rule 72(a), a district court may modify or set aside such an order if it is “clearly erroneous or contrary to law.” Id.; Marks v. Struble, 347 F. Supp. 2d 136, 149 (D.N.J. 2004). The burden rests with the objecting party. Id. (quoting Cardona v. Gen. Motors Corp., 942 F. Supp. 968, 971 (D.N.J. 1996)). A finding is “clearly erroneous” when the court is “left with the definite and firm conviction that a mistake has been committed” after reviewing the record. Id. (quoting Dome Petroleum Ltd. v. Emps. Mut. Liab. Ins. Co. of Wisconsin, 131 F.R.D. 63, 65 (D.N.J. 1990)). A finding is “contrary to law” only when the magistrate judge has misinterpreted or misapplied the governing law. Id. (citing Gunter v. Ridgewood Energy Corp., 32 F. Supp. 2d 162, 164 (D.N.J. 1998)). Mere disagreement with a magistrate judge’s ruling does not satisfy this deferential standard, and discovery rulings are entitled to substantial deference, as magistrate judges have broad discretion to manage discovery and resolve discovery disputes. Andrews v. Goodyear Tire & Rubber Co., 191 F.R.D. 59, 68 (D.N.J. 2000); Cooper Hosp./Univ. Med. Ctr. v. Sullivan, 183 F.R.D. 119, 127 (D.N.J. 1998). III. DISCUSSION Plaintiff’s Appeal fails at the outset because she cannot establish that Judge Clark’s April 22, 2026 Order is clearly erroneous or contrary to law. Plaintiff identifies no legal or factual error; instead, she merely disagrees with the result and attempts to relitigate issues that have already been adjudicated and previously denied. (See D.E. 67.) Plaintiff does not address the Rule 72(a) standard, and courts in this District routinely affirm magistrate judges’ discovery rulings on that basis. See Champion Painting Specialty Servs. Corp. v. Delaware River Port Auth., 658 F. Supp. 3d 241, 248 (D.N.J. 2023); Jones v. PHH Mortg. Corp., 814 F. Supp. 3d 531, 534 (D.N.J. 2026). Even if Plaintiff had addressed the Rule 72(a) standard, the Appeal still fails because the Order correctly applied the governing law to the facts. Rule 30(b)(4) allows depositions to proceed remotely only by stipulation or court order, and neither exists here. Fed. R. Civ. P. 30(b)(4). The Rules do not create any presumption in favor of remote depositions, and courts have recognized that the examining party generally selects the manner of examination. See Grady v. Target Store #2381, No. 17-4160, 2019 WL 2024507, at *2 (D.N.J. May 8, 2019) (citing Interlego A.G. v. Leslie-Henry Co., 32 F.R.D. 9, 11 (M.D. Pa. 1963)). As Plaintiff contends that she would be in danger if she appears in person at defense counsel’s office, Plaintiff may come into this Court for the deposition. (D.E. 67 at 5.) In any event, if Plaintiff intends to prosecute this action, she must appear for her deposition. Failure to do so may result in dismissal. V. CONCLUSION For the foregoing reasons, Plaintiff’s Appeal is DENIED. An appropriate order follows.
/s/ Susan D. Wigenton SUSAN D. WIGENTON, U.S.D.J.
Orig: Clerk cc: Parties James B. Clark, U.S.M.J.
Free access — add to your briefcase to read the full text and ask questions with AI
Candice Lue v. Teva Pharmaceuticals USA, Inc. et al. (Candice Lue v. Teva Pharmaceuticals USA, Inc. et al.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.